HomeIGMS • NASDAQ
add
IGM Biosciences Inc
Previous close
$1.15
Day range
$1.11 - $1.20
Year range
$0.92 - $22.50
Market cap
70.94M USD
Avg Volume
159.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 499.00K | 0.40% |
Operating expense | 10.96M | 4.04% |
Net income | -52.89M | -6.17% |
Net profit margin | -10.60K | -5.75% |
Earnings per share | -0.86 | -3.61% |
EBITDA | -28.75M | 44.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.11M | -48.22% |
Total assets | 206.89M | -45.00% |
Total liabilities | 206.19M | -4.04% |
Total equity | 698.00K | — |
Shares outstanding | 60.12M | — |
Price to book | 115.00 | — |
Return on assets | -32.82% | — |
Return on capital | -112.40% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -52.89M | -6.17% |
Cash from operations | -32.52M | 23.33% |
Cash from investing | 42.74M | 394.00% |
Cash from financing | 5.00K | -96.71% |
Net change in cash | 10.22M | 130.41% |
Free cash flow | -20.10M | 33.79% |
About
Founded
1993
Website
Employees
54
